- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03191656
REDUCE LAP-HF III Corvia Protocol 1701 (REDUCELAPHFIII)
February 6, 2024 updated by: Corvia Medical
A Post-Market Clinical Follow-up Study to Evaluate the Corvia Medical, Inc. InterAtrial Shunt Device - IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
This is a post market trial to be conducted at sites in Germany.
The device has CE approval in the EU.
The purpose of this observational registry is to collect post market data in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety and quality of life outcomes as a new treatment for patients with heart failure in a "real world" practice setting.
Study Overview
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jan Komtebedde, DVM
- Phone Number: 978-654-6113
- Email: jkomtebedde@corviamedical.com
Study Contact Backup
- Name: Felix DeLaRosa
- Email: fdelarosa@corviamedical.com
Study Locations
-
-
-
Bad Nauheim, Germany
- Recruiting
- Herzzentrum der Kerckhoff-Klinik
-
Contact:
- Mortiz Hass, MD
-
Bad Oeynhausen, Germany
- Recruiting
- Herz- und Diabeteszentrum Nordrhein-Westfalen Klinik für Kardiologie
-
Contact:
- Daniel Dumitrescu, MD
-
Bad Segeberg, Germany
- Recruiting
- Segeberger Kliniken Gmbh
-
Contact:
- Leon Iden, MD
-
Berlin, Germany
- Recruiting
- Unfallkrankenhaus Berlin
-
Contact:
- Sebasian Winkler, MD
-
Chemnitz, Germany
- Recruiting
- Klinikum Chemnitz gGmbH
-
Contact:
- Karim Ibrahim, MD
-
Detmold, Germany
- Terminated
- Klinikum Lippe GmbH
-
Dresden, Germany
- Recruiting
- Herzzentrum Dresden GmbH
-
Contact:
- Axel Linke, MD
-
Düsseldorf, Germany
- Recruiting
- Universitätsklinikum Düsseldorf Klinik für Kardiologie, Pneumologie u. Angiologie
-
Contact:
- Ralf Westenfeld, MD
-
Essen, Germany
- Terminated
- Elisabeth-Krankenhaus Essen
-
Giessen, Germany
- Recruiting
- Universitätsklinikum Gießen
-
Contact:
- Holger Nef, MD
-
Göttingen, Germany
- Recruiting
- Universitätsklinikum Göttingen
-
Contact:
- Gerd Hasenfuss, MD
-
Halle, Germany
- Recruiting
- Universitäts Klinikum Halle
-
Contact:
- J Tongers, MD
-
Heilbronn, Germany
- Terminated
- Klinikum am Plattenwald Bad Friedrichshall
-
Karlsburg, Germany
- Recruiting
- Klinikum Karlsburg
-
Contact:
- Basil Alkhlout, MD
-
Kiel, Germany
- Terminated
- Klinik für Innere Medizin III mit den Schwerpunkten Kardiologie, Angiologie und internistische
-
Köln, Germany
- Recruiting
- Herzzentrum der Universität zu Köln
-
Contact:
- Roman Pfister, MD
-
Leipzig, Germany
- Terminated
- Klinikum Sankt Georg
-
Lübeck, Germany
- Recruiting
- Universitatsklinikum Schleswig-Holstein
-
Contact:
- T. Schmidt, MD
-
Münster, Germany
- Recruiting
- Universitätsklinikum Münster
-
Contact:
- Rudin Pistulli, MD
-
Osnabrück, Germany
- Terminated
- Niels-Stensen-Kliniken - Marienhospital
-
Paderborn, Germany
- Terminated
- St Vincenz-Kranenhaus
-
Rotenburg, Germany
- Terminated
- Herz-Kreislauf-Zentrum Rotenburg
-
Schwerin, Germany, 19049
- Recruiting
- HELIOS Kliniken Schwerin
-
Contact:
- Pauline Herke
-
Principal Investigator:
- Philipp Hammer, MD
-
Wittenberg, Germany
- Recruiting
- Evangelisches Krankenhaus Paul Gerhardt Stift - Unfallstation
-
Contact:
- Franz Kleber, Prof
-
Zwickaü, Germany
- Recruiting
- Heinrich Braun Klinikum
-
Contact:
- Holger Sigusch, MD
-
Ülm, Germany
- Recruiting
- Universitätsklinik Ulm-Keßler
-
Contact:
- Mirjam Kessler, MD
-
-
-
-
-
Solothurn, Switzerland
- Recruiting
- Bürgelspital Solothurn
-
Contact:
- Rolf Vogel, Prof
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with heart failure with preserved (HFpEF) or mid-range ejection fraction (HFmrEF) with elevated left atrial pressures, who remain symptomatic despite standard Guideline Directed Medical Therapy (GDMT), in accordance with CE-mark approved labeling.
Description
This is a post market registry so no criteria requirements (only recommendations).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serious Adverse Events
Time Frame: 30 days
|
Device and or procedure related serious adverse cardiac events
|
30 days
|
New York Heart Classification
Time Frame: 12 months
|
Improvement in NYHA Classification
|
12 months
|
Quality of Life Improvement (KCCQ score)
Time Frame: 12 months
|
Improvement in KCCQ score
|
12 months
|
Quality of Life Improvement (EQ5D)
Time Frame: 12 months
|
Improvement in EQ5D score
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 12, 2017
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2028
Study Registration Dates
First Submitted
June 12, 2017
First Submitted That Met QC Criteria
June 16, 2017
First Posted (Actual)
June 19, 2017
Study Record Updates
Last Update Posted (Actual)
February 8, 2024
Last Update Submitted That Met QC Criteria
February 6, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1701
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
Clinical Trials on IASD Implant
-
Corvia MedicalActive, not recruiting
-
Corvia MedicalActive, not recruitingHeart FailureUnited States, Austria, Japan, Australia, Netherlands, Canada, France, Denmark, Germany, Spain, Italy, Belgium, Croatia, Poland, United Kingdom
-
Corvia MedicalCompletedHeart FailureNew Zealand, Austria, France, Denmark, Germany, Netherlands, United Kingdom, Australia, Czechia, Belgium, Poland
-
Corvia MedicalCompletedHeart FailureDenmark, Australia, Czechia
-
Corvia MedicalWithdrawnHeart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction
-
Corvia MedicalActive, not recruitingHeart FailureUnited States, Netherlands, Australia, Belgium, United Kingdom
-
Corvia MedicalRecruitingHeart Failure | Heart Failure, DiastolicUnited States, Germany, Australia, Netherlands, Belgium, Austria
-
Aula Dental AvanzadaRecruiting
-
University of Sao PauloCompletedCataract | AstigmatismBrazil
-
Aula Dental AvanzadaCompleted